Skip to main content

Glucagon: Everything You Need To Know

Published: 8/21/23 11:20 am
By April Hopcroft

Baqsimi GlucagonGlucagon is used to treat dangerously low blood sugar. Newer glucagon options, including autoinjectors and nasal glucagon, offer more convenience for people with diabetes. 

Glucagon is a hormone made by alpha cells in the pancreas that increases blood glucose. Glucagon raises blood sugar by telling the liver to release stored sugar into the bloodstream and make new sugar.

Glucagon is used to treat severe hypoglycemia, or dangerously low blood sugar. 

Who uses glucagon? 

People with diabetes use glucagon to treat severe hypoglycemia. Glucagon is produced naturally in the body when blood sugars drop, while synthetic glucagon is given by injection to raise blood sugars.

Hypoglycemia varies in severity and can occur for a variety of reasons, such as doing too much exercise, skipping a meal, or giving yourself too much insulin. 

Mild hypoglycemia can often be treated by eating carbohydrates. In cases of severe hypoglycemia, a person may be unable to swallow food or drinks to treat the low on their own. Glucagon can be administered in an emergency situation (when someone is unresponsive, having a seizure, or in a coma) to quickly raise blood glucose levels.

People with diabetes who use insulin or sulfonylureas are at the greatest risk of severe hypoglycemia. It’s a good idea for anyone with diabetes who uses insulin or sulfonylureas to have a prescription for glucagon. Ask your provider for a prescription if you don’t already have one. 

What’s the difference between glucagon and insulin?

Insulin and glucagon are both hormones produced by the pancreas that work together to regulate blood sugar. When blood sugar is too high, the beta cells of the pancreas release insulin to lower blood sugar. Meanwhile, when blood sugar is too low, the alpha cells of the pancreas release glucagon to raise blood sugar. 

Ready-to-use glucagon 

Until 2019, traditional glucagon emergency kits were used to treat severe hypoglycemia. These kits required a multi-step reconstitution (mixing) process to turn powdered glucagon into a liquid that could be injected. 

In the stress of a severe hypoglycemic event, caregivers may become overwhelmed by the different steps of the preparation process. As a result, they may not be able to deliver the rescue glucagon correctly. These challenges contribute to the underuse of glucagon. 

Ready-to-use emergency glucagons, or next-generation glucagons, were launched in 2019 with the approval of Gvoke HypoPen. These newer therapies offer greater convenience for people with diabetes and their caregivers, because they don’t require a complicated reconstitution process. Autoinjectors and nasal glucagon provide good options for children and others who may be afraid of needles. Lilly discontinued its traditional glucagon emergency kit at the end of 2022, though other companies like Novo Nordisk and Amphastar still offer traditional glucagon kits. 

What types of ready-to-use glucagon are available? 

  • Autoinjectors: These glucagons are ready to inject (like an EpiPen for allergies) and are administered by a caregiver or trained individual, such as a family member or friend. Gvoke HypoPen is approved for people with diabetes ages 2 and up. Gvoke is also available as a pre-filled syringe, and GvokeKit offers a premixed vial and syringe. Zegalogue is approved for people with diabetes ages 6 and up. It is also available as a pre-filled syringe.  

  • Nasal glucagon: This is a needle-free glucagon option. Since it does not require inhalation, it can be successfully administered by another person if the receiver is unconscious. Baqsimi is approved for people with diabetes ages 4 and up. It is currently the only nasal glucagon option. 

What are the benefits of ready-to-use glucagon? 

Ready-to-use glucagon is a quick way to treat severe hypoglycemia – and a better alternative to calling an ambulance. 

Research on Zegalogue found that 99% of people recovered and returned to regular blood sugar levels within just 15 minutes of using Zegalogue. For comparison, the recovery time for traditional glucagon emergency kits can be up to 30-45 minutes. 

Ready-to-use glucagons are easy for caregivers, family members, and other community members to use so they can help in an emergency. These newer forms are also smaller and more discreet than the bright orange traditional glucagon kits. This means you can easily stash a backup at school, work, or carry it with you out and about as you might do with an EpiPen.

What are the drawbacks of glucagon? 

Glucagon can cause side effects such as:

  • Nausea 

  • Vomiting

  • Diarrhea

  • Hives

  • Headache

  • Injection site pain

  • Rapid heartbeat 

Taking nasal glucagon may also cause upper respiratory tract irritation. In rare instances, people who are allergic to the glucagon formulation or any of the other ingredients in ready-to-use glucagon may experience an allergic reaction. If you experience symptoms of a severe allergic reaction – rash, difficulty breathing, or low blood pressure – call your healthcare provider or get medical help immediately. 

Another drawback is glucagon can be expensive, especially considering that it’s not used often. However, knowing that you have treatment readily available in case of an emergency is priceless. Many companies offer patient assistance programs to reduce the cost of glucagons, such as Gvoke and Baqsimi.

Who should not use glucagon?

There are certain groups of people who should avoid taking glucagon, including:

  • Those with a tumor in their pancreas or adrenal gland.

  • People who are allergic to any of the ingredients in ready-to-use glucagons.

  • People who are pregnant, plan to become pregnant, or are breastfeeding should also consult their healthcare provider to discuss using glucagon.

Learn more about hypoglycemia and glucagon here: 

Photo credit: Susannah Chen

What do you think?

About the authors

April Hopcroft joined diaTribe in 2023 as a Staff Writer after co-leading the Diabetes Therapy team at Close Concerns. She graduated from Smith College in 2021, where she majored in... Read the full bio »